(lp0
S'BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in ... PR Newswire  - Mar 31, 2017 RALEIGH, N.C., March 31, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that two important new patents were granted extending patent protection around all three of its FDA approved products, BELBUCA&nbsp;...'
p1
aS'Market Sheet: Watching the Levels for BioDelivery Sciences International, Inc ... Benton Bulletin - 11 hours ago BioDelivery Sciences International, Inc.  has a current Piotroski F-Score of 3. The mission of the F-Score is to help spot companies with strengthening balance sheets, and to weed out poor performers.'
p2
aS'BioDelivery Sciences Reacquires License to BELBUCA from Endo Pharmaceuticals PR Newswire  - Dec 8, 2016 RALEIGH, N.C., Dec. 8, 2016 /PRNewswire/ --BioDelivery Sciences International, Inc.  announced that it has entered into an agreement with Endo Pharmaceuticals, Inc.  terminating their licensing of rights for BELBUCA&nbsp;...BioDelivery Regains Belbuca Opioid Rights  - InvestopediaEndo returns licensing rights to opioid drug, lays off 375 sales reps - Philly.com'
p3
aS'BioDelivery Sciences Secures Debt Financing with CRG PR Newswire  - Feb 23, 2017 RALEIGH, N.C., Feb. 23, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced today that it has entered into a senior credit facility with affiliates of CRG LP, a healthcare-focused investment firm, to retire its ...'
p4
aS'BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President ... PR Newswire  - Dec 14, 2016 RALEIGH, N.C., Dec. 14, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc.  announced that Peter Ginsberg has joined the company as Vice President of Business Development.Company Update : Why BioDelivery Sciences International, Inc ... - Smarter AnalystOn heels of Belbuca reacquisition, BDSI makes business development hire - Triangle Business Journal'
p5
aS'Watching Shares of BioDelivery Sciences International Inc  Rives Journal - 16 hours ago Keeping an eye on moving averages for BioDelivery Sciences International Inc , the 50-day is 1.91, the 200-day is at 2.15, and the 7-day is 1.73.'
p6
aS'BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values ... Yahoo Finance - Mar 28, 2017 BioDelivery Sciences International went up 8.57% to close at $1.90 on Monday. The stock traded between $1.90 and $1.76 on volume of 409,980 shares traded.BioDelivery Sciences: 2017 Will Be Key Year For ~$2 Biopharma - Seeking AlphaBioDelivery Sciences International, Inc.  Files An 8-K Completion ... - Market Exclusive'
p7
aS'BioDelivery Sciences to Hold Analyst and Investor Day to Discuss BELBUCA ... PR Newswire  - Jan 26, 2017 RALEIGH, N.C., Jan. 26, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  will host an event for analysts and investors from 12:00 PM - 2:30 PM Eastern Time on Wednesday, February 1st, 2017, in New York City, to discuss&nbsp;...'
p8
aS'BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and ... PR Newswire  - Mar 17, 2017 RALEIGH, N.C., March 17, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc.  today reported financial results for the fourth quarter and full year ended December 31, 2016, and provided an update on recent business highlights and&nbsp;...'
p9
aS"Can BioDelivery Succeed With Belbuca? Seeking Alpha - Feb 10, 2017 BioDelivery  gave a pretty good presentation about Belbuca and the company's sales and marketing strategy going forward."
p10
a.